Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Signoretti

Showing results (181-190 of 257) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2019
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid FeaturesBradley A McGregor, Rana R McKay, David A Braun, et al.
British Journal of Cancer|December 21, 2019
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinomaAmin H Nassar, Kent W Mouw, Opeyemi Jegede, et al.
Nature Communications|April 10, 2019
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosisYilong Zou, Michael J Palte, Amy A Deik, et al.
Cell Reports|February 14, 2026
Generation of a comprehensive epigenomic atlas in clear cell renal cell carcinoma informs kidney cancer progression and heritabilitySarah Abou Alaiwi, Elio Adib, Ziwei Zhang, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinomaPrathyusha Konda, Cary N Weiss, Yantong Cui, et al.
Nature Communications|September 27, 2019
Metabolomic adaptations and correlates of survival to immune checkpoint blockadeHaoxin Li, Kevin Bullock, Carino Gurjao, et al.
Genes & Development|November 16, 2019
The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesisMatthew G Oser, Amin H Sabet, Wenhua Gao, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
EED Maintains the Small Cell Lung Cancer Neuroendocrine Phenotype and Drives Lung Cancer Histological TransformationYixiang Li, Yasmin N Laimon, Hyeonseo Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2020
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell CarcinomaMiriam Ficial, Opeyemi A Jegede, Miriam Sant'Angelo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma PatientsThomas Denize, Opeyemi A Jegede, Sayed Matar, et al.
Pageof 26

Showing results (181-190 of 257) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2019
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid FeaturesBradley A McGregor, Rana R McKay, David A Braun, et al.
British Journal of Cancer|December 21, 2019
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinomaAmin H Nassar, Kent W Mouw, Opeyemi Jegede, et al.
Nature Communications|April 10, 2019
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosisYilong Zou, Michael J Palte, Amy A Deik, et al.
Cell Reports|February 14, 2026
Generation of a comprehensive epigenomic atlas in clear cell renal cell carcinoma informs kidney cancer progression and heritabilitySarah Abou Alaiwi, Elio Adib, Ziwei Zhang, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinomaPrathyusha Konda, Cary N Weiss, Yantong Cui, et al.
Nature Communications|September 27, 2019
Metabolomic adaptations and correlates of survival to immune checkpoint blockadeHaoxin Li, Kevin Bullock, Carino Gurjao, et al.
Genes & Development|November 16, 2019
The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesisMatthew G Oser, Amin H Sabet, Wenhua Gao, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
EED Maintains the Small Cell Lung Cancer Neuroendocrine Phenotype and Drives Lung Cancer Histological TransformationYixiang Li, Yasmin N Laimon, Hyeonseo Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2020
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell CarcinomaMiriam Ficial, Opeyemi A Jegede, Miriam Sant'Angelo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma PatientsThomas Denize, Opeyemi A Jegede, Sayed Matar, et al.
Pageof 26